How many employees does Halozyme Therapeutics, Inc. have?

Halozyme Therapeutics, Inc. reported 423 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 17, 2026. That is up 20.9% from a year earlier.

What is Halozyme Therapeutics, Inc.'s revenue per employee?

Halozyme Therapeutics, Inc. brought in $1.40B of revenue in fiscal Dec 2025, which is $3.30M per employee. That ranks 1 of 39 companies we track in Biotechnology, where the median is $602K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Halozyme Therapeutics, Inc. employees and revenue per employee

HALO · Biotechnology · $13.0B market cap

Halozyme Therapeutics, Inc. had 423 employees at the end of fiscal Dec 2025, up 20.9% from a year earlier. Revenue for the year was $1.40B, up 37.6% from a year earlier, or $3.30M per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

423

+20.9% YoY

Revenue

$1.40B

+37.6% YoY

Revenue / employee

$3.30M

Peer median $602K

Rank in industry

1 of 39

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

HALO employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	423	$1.40B	$3.30M	+20.9%	+37.6%
Dec 2024	350	$1.02B	$2.90M	-6.2%	+22.4%
Dec 2023	373	$829M	$2.22M	-5.1%	+25.6%
Dec 2022	393	$660M	$1.68M	+171.0%	+48.9%
Dec 2021	145	$443M	$3.06M	+6.6%	+65.7%
Dec 2020	136	$268M	$1.97M	+3.0%	+36.5%
Dec 2019	132	$196M	$1.48M	-53.0%	+29.1%
Dec 2018	281	$152M	$540K	+10.2%	-52.0%
Dec 2017	255	$317M	$1.24M	-1.5%	+115.8%
Dec 2016	259	$147M	$566K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Halozyme Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
HALO Halozyme Therapeutics, Inc.	423	$1.40B	$3.30M	Efficient growth
EXEL Exelixis, Inc.	1,077	$2.32B	$2.15M	Leaner
BCRX BioCryst Pharmaceuticals, Inc.	435	$875M	$2.01M	Leaner
PTCT PTC Therapeutics, Inc.	991	$1.73B	$1.75M	Efficient growth
MDGL Madrigal Pharmaceuticals, Inc.	915	$958M	$1.05M	Efficient growth
IONS Ionis Pharmaceuticals, Inc.	1,402	$944M	$673K	Efficient growth
MRNA Moderna, Inc.	4,700	$1.94B	$414K	Contracting
TECH Bio-Techne Corporation	3,000	$1.22B	$405K	Contracting
LEGN Legend Biotech Corporation	2,900	$1.03B	$355K	Efficient growth

Every Healthcare company

Questions about Halozyme Therapeutics, Inc.

How many employees does Halozyme Therapeutics, Inc. have?: Halozyme Therapeutics, Inc. reported 423 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 17, 2026. That is up 20.9% from a year earlier.
What is Halozyme Therapeutics, Inc.'s revenue per employee?: Halozyme Therapeutics, Inc. brought in $1.40B of revenue in fiscal Dec 2025, which is $3.30M per employee. That ranks 1 of 39 companies we track in Biotechnology, where the median is $602K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare HALO with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Halozyme Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 17, 2026. This is data, not a recommendation to buy or sell HALO.